Colony Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,720
| Closed | -$316K | – | 850 |
|
|
2021
Q2 | $316K | Sell |
1,720
-296
| -15% | -$54.4K | 0.01% | 621 |
|
|
2021
Q1 | $308K | Sell |
2,016
-1,051
| -34% | -$161K | 0.01% | 638 |
|
|
2020
Q4 | $479K | Sell |
3,067
-542
| -15% | -$84.6K | 0.01% | 514 |
|
|
2020
Q3 | $413K | Sell |
3,609
-46
| -1% | -$5.26K | 0.01% | 508 |
|
|
2020
Q2 | $410K | Sell |
3,655
-104
| -3% | -$11.7K | 0.01% | 492 |
|
|
2020
Q1 | $338K | Buy |
+3,759
| New | +$338K | 0.01% | 530 |
|
|
2019
Q3 | – | Sell |
-2,960
| Closed | -$388K | – | 734 |
|
|
2019
Q2 | $388K | Sell |
2,960
-815
| -22% | -$107K | 0.01% | 553 |
|
|
2019
Q1 | $510K | Buy |
+3,775
| New | +$510K | 0.02% | 392 |
|